Trademark Search
Owners
Sun Pharmaceutical Industries Limited
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML)
on 17 Nov 2020
Last Applicant/ Owned by
Western Express Highway, Goregaon (E)
Mumbai, Maharashtra
IN
400063
Serial Number
88125486 filed on 20th Sep 2018
Registration Number
6200988 registered on 17th Nov 2020
Correspondent Address
Craig Kuchii, Esq.
SUN PHARMACEUTICAL INDUSTRIES, INC.
2 INDEPENDENCE WAY
INTELLECTUAL PROPERTY DEPT.
PRINCETON, NJ 08540
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML)"
The mark consists of a pink outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a pink arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in pink, with the words "1,500 mg per 150 mL (10 mg/mL)" in white letters. The color white in the rRead More
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
08th Jul 2020
08th Jul 2020
medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
08th Jul 2020
08th Jul 2020
No 88125486
No Service/Collective Mark
No STM-476US
No
No
No
No
No
No
No
No
26.11.13 -
Two rectangles
26.11.21 -
Rectangles that are completely or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of a pink outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a pink arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in pink, with the words "1,500 mg per 150 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 17th Nov 2020 | REGISTERED-PRINCIPAL REGISTER |
| 16th Oct 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 15th Oct 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 13th Oct 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| 13th Oct 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Sep 2020 | USE AMENDMENT FILED |
| 29th Sep 2020 | TEAS STATEMENT OF USE RECEIVED |
| 24th Apr 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Apr 2020 | EXTENSION 2 FILED |
| 22nd Apr 2020 | TEAS EXTENSION RECEIVED |
